MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

509830

Report Date :

24.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

INTAS PHARMACEUTICALS LIMITED (w.e.f. 30.03.1995)

 

 

Formerly Known As :

INTAS LABORATORIES LIMITED (w.e.f. 29.03.1995)

 

INTAS LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

Corporate House, Near Sola Bridge, S. G. Highway, Thaltej, Ahmedabad – 380054, Gujarat

Tel. No.:

91-79-39837000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

31.05.1985

 

 

Com. Reg. No.:

04-007866

 

 

Capital Investment / Paid-up Capital :

INR 1147.440 Million

 

 

CIN No.:

[Company Identification No.]

U24231GJ1985PLC007866

 

 

IEC No.:

[Import-Export Code No.]

0896004341

 

 

GSTN :

[Goods & Service Tax Registration No.]

24AAACI5120L1ZU

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACI5120L

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturing, Marketing, Distribution, Sale of Finished Pharmaceutical Formulations, Active Pharmaceutical Ingredient (API), Medical Appliances, Medical Devices. (Registered Activity and also confirmed by management)

 

 

No. of Employees :

12000 (approximately)

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A++

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

 

Status :

Excellent

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 1985 and it is a pharmaceutical manufacturing company based in Ahmedabad, Gujarat.

 
For the financial year 2017, the company has achieved revenue growth of 14.90% as compared to the previous year along with a decent profit margin of 15.88%.

The sound financial profile of the company is marked by adequate net worth base along with negligible debt balance sheet profile.


The rating further derive strength from the vast experience of its promoters in the pharmaceutical industry, established marketing and distribution network, diversified product portfolio along with healthy growth prospect of Indian pharmaceutical industry.

 
Rating, however, continues to be constrained on account of its uncertainty associated with its bio-similar product pipeline and exposure to inherent regulatory risk associated with the pharmaceutical industry coupled with intense competition in both domestic and export markets.


Business is active. Payments seems to be regular and as per commitments.

 
In view of strong financial and established position, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long Term Borrowing = AA

Rating Explanation

High degree of safety and very low credit risk.

Date

05.04.2018

 

Rating Agency Name

CARE

Rating

Short Term Borrowing: A1+

Rating Explanation

Very strong degree of safety and carry lowest credit risk.

Date

05.04.2018

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 24.05.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Prithvi

Designation :

Treasury Manager

Contact No.:

91-79-66523100

Date:

17.05.2018

 

 

LOCATIONS

 

Registered Office :

Corporate House, Near Sola Bridge, S. G. Highway, Thaltej, Ahmedabad – 380054, Gujarat, India

Tel. No.:

91-79-66523100/ 26576655

Fax No.:

91-79-26578862

E-Mail :

manoj_nair@intaspharma.com

Website :

www.intaspharma.com

 

 

Corporate Office :

2nd Floor, Chinubhai Centre, Ashram Road, Ahmedabad - 380009, Gujarat, India

 

 

Factory 1 :

Plot No.: 423, P/A, GIDC, Moraiya, Sarkhej Bawala Road, Ral – Sanand, Moraiya, Ahmedabad - 382213, Gujarat, India

Tel. No.:

91-2717-660100, 660101

Fax No.:

91-2717-251189

 

 

Factory 2 :

7/3, GIDC Estate, Behind Dena Bank, Vatva, Ahmedabad – 382445, Gujarat, India

Tel. No.:

91-79-25830207/25831279

 

Factory 3 :

Camp Road, Selaqui, Dehradun – 248001, Uttrakhand, India

Tel. No.:

91-135-2698659/2699098/2699174/2699175 

Fax No.:

91-135-2699099

 

Factory 4 :

Survey No. 44-B, Naldhari Village, Valia Taluka - 393135. District Bharuch, Gujarat, India

Tel. No.:

91-2643-270015/270389

 

Factory 5 :

Plot No. 457-458, Sarkhej Bavla Highway, Matoda Village, Sanand Taluka, Ahmedabad – 382210, Gujarat, India

Tel. No.:

91-2717-661298

Fax No.:

91-2717-661106

 

Factory 6 :

Plot No. 5, 6, 7, Pharmez, Sarkhej-Bavla Highway, Matoda Village, Sanand Taluka, Ahmedabad - 382 210, Gujarat, India

Tel. No.:

91-2717-619100

Fax No.:

91-2717-619999

 

Factory 7 :

Near IOC Depo, N.H. No. 31A, Bhagey Khola, Majhitar, Rangpo – 737132, East Sikkim, Himalaya, India

Tel. No.:

91-3592-246417/18/32

Fax No.:

91-3592-246417

 

Factory 7 :

85-87, Kailash Industrial Estate, Iyava Village, Sanand Taluka, Ahmedabad – 382210, Gujarat, India

Tel. No.:

91-2717-284188/89/90

 

 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Mr. Urmish Hasmukh Chudgar

Designation :

Managing Director

Address :

16, Nishant Bunglows Part-1, Behind Shyamal Row House Satellite Road, Ahmedabad - 380015, Gujarat, India

Date of Birth/Age :

16.02.1959

Qualification :

MD in Oncology and Haemetoly

Date of Appointment :

30.09.1996

PAN No.:

ABHPC1733G

DIN No.:

00096080

 

 

Name :

Mr. Binish Hasmukh Chudgar

Designation :

Managing Director

Address :

11, Akashneem Bunglows, Vastrapur, Ahmedabad-380001, Gujarat, India

Date of Birth/Age :

01.12.1963

Qualification :

B Com, MBA

Date of Appointment :

31.05.1985

PAN No.:

ABDPC6876C

DIN No.:

00119503

 

 

 

Name :

Mr. Nimish Hasmukh Bhai Chudgar

Designation :

Managing Director

Address :

13-14, Sanidhya Bunglows, Near Someshwar Complex, Shyamal Cross Road, Satellite, Ahmedabad-380053, Gujarat, India

Date of Birth/Age :

19.08.1960

Qualification :

B. SC

Date of Appointment :

31.05.1985

PAN No.:

ABDPC6875B

DIN No.:

00212400

 

 

Name :

Mr. Jayesh Shantilal Shah

Designation :

Whole Time Director

Address :

15, Nirgun Bungalows, Near Ambrakadamb Super Society, Ramdev Nagar, Char Rasta, Ahmedabad - 380015, Gujarat, India

Date of Appointment :

21.03.2018

PAN No.:

ACSPS6242G

DIN No.:

02681464

 

 

Name :

Mr. Hasmukh Chudgar

Designation :

Whole-time Director

Address :

13-14, Sanidhya Bunglows, Near Someshwar Complex, Shyamal Cross Road, Satellite, Ahmedabad-380053, Gujarat, India

Date of Birth/Age :

16.05.1933

Qualification :

B Pharm

Date of Appointment :

31.05.1985

PAN No.:

AARPC4022H

DIN No.:

00172265

 

 

Name :

Ms. Kusumben Hasmukhbhai Chudgar

Designation :

Director

Address :

13-14, Sanidhya Bunglows, Near Someshwar Complex, Shyamal Cross Road, Satellite, Ahmedabad-380053, Gujarat, India

Date of Appointment :

01.04.2015

DIN No.:

00279041

 

Name :

Mr. Surender Kumar Tuteja

Designation :

Director

Address :

S-307, 2nd Floor, Panchsheel Park, New Delhi-110017, India

Date of Appointment :

09.02.2011

DIN No.:

00594076

 

Name :

Mr. Tilokchand Punamchand Ostwal

Designation :

Director

Address :

103 Falcon's Crest, G.D. Ambekar Marg, Parel, Mumbai-400012, Maharashtra, India

Date of Appointment :

19.03.2011

DIN No.:

00821268

 

 

Name :

Mr. Hemant Devidas Sheth

Designation :

Director

Address :

201, Angan Building, Plot No. 40, T. V. Chidambaram Marg, Sion (East), Mumbai – 400022, Maharashtra, India  

Date of Appointment :

09.02.2011

DIN No.:

01261486

 

Name :

Mr. Sanjiv Dwarkanath Kaul

Designation :

Nominee Director

Address :

22, Siris Road, DLF Qutab Enclave, Phase-3, Gurugram - 122002, Haryana, India

Date of Appointment :

16.06.2012

DIN No.:

01550413

 

Name :

Mr. John Geoffrey Goddard

Designation :

Director

Address :

38 Delvino Road, Fulham, London, Sw64aj, United Kingdom

Date of Appointment :

09.02.2011

DIN No.:

03420601

 

Name :

Mr. Venkatesh Ratnasami

Designation :

Nominee Director

Address :

Old No- 12, New No 25 C-1, Shanmuga Villa, Venkartaman Street, T Nagar, Chennai – 600017, Tamilnadu, India

Date of Appointment :

13.11.2014

DIN No.:

03433678

 

 

KEY EXECUTIVES

 

Name :

Mr. Jayesh Shantilal Shah

Designation :

Chief Executive Officer

Address :

15, Nirgun Bungalows, Near Ambrakadamb Super Society Ramdev Nagar Char Rasta Ahmedabad – 380015, Gujarat, India

Date of Birth/Age :

11.02.1964

Date of Appointment :

12.03.2015

PAN No.:

ACSPS6242G

 

 

Name :

Mr. Manoj Narayanan Nair

Designation :

Company Secretary

Address :

"Laxmi Nivas" 648/1 Sector-4 C, Gandhinagar Gandhinagar – 382006, Gujarat, India

Date of Birth/Age :

20.10.1979

Date of Appointment :

08.06.2007

PAN No.:

AEBPN7909Q

 

 

Name :

Mr. Prithvi

Designation :

Treasury Manager

 

 

MAJOR SHAREHOLDERS

 

AS ON 29.09.2017

 

Names of Shareholders

 

No. of Shares

Hasmukh Kesarichand Chudgar

 

213145

Hasmukh Kesarichand Chudgar

 

3422804

Kusumben Hasmukh Chudgar

 

2367503

Kusumben Hasmukh Chudgar

 

38462

Binish Hasmukh Chudgar

 

5945735

Binish Hasmukh Chudgar

 

301874

Bindiben Binish Chudgar

 

6944851

Nimish Hasmukh Chudgar

 

6164115

Nimish Hasmukh Chudgar

 

313054

Binaben Nimish Chudgar

 

5483291

Urmish Hasmukh Chudgar

 

151995

Parul Urmish Chudgar

 

7032831

Shail Urmish Chudgar

 

4563868

Shail Urmish Chudgar

 

233099

Intas Enterprise Private Limited

 

4106667

Equatorial Private Limited

 

47432000

Cytas Research Limited

 

1509131

Dunearn Investments Pte Limited

 

11621100

Mace CIPEF Limited

 

3382654

Mace CGPE Limited

 

66570

Crimson Investments Limited

 

3397485

Vikas Srivastava as a Trustee of Link Investment Trust

 

51738

Total

 

114743972

 

AS ON 29.09.2017

 

Equity Share Break up

Percentage

Category

 

Promoters – [Individual/Hindu Undivided Family – Indian]

37.63

Promoters – [Bodies corporate]

46.23

Public/Other than promoters -[Bodies corporate]

16.09

Public/Other than promoters – (Other -Trust)

0.05

Total

100.00

 

 


 

BUSINESS DETAILS

 

Line of Business :

Manufacturing, Marketing, Distribution, Sale of Finished Pharmaceutical Formulations, Active Pharmaceutical Ingredient (API), Medical Appliances, Medical Devices. (Registered Activity and also confirmed by management)

 

 

Products :

NIC Code No.

Product/Services Description

210

Manufacturing, Marketing, Distribution, Sale of finished Pharmaceutical Formulations, Active Pharmaceutical Ingredient (API), Medical Appliances, Medical Devices.

 

ITC Code No.

Product Description

30049049

Injection

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Divulged

 

 

Exports :

 

Product :

  • Finished Goods

Countries :

  • United States of America
  • Europe

 

 

Imports :

 

Product :

  • Raw Material

Countries :

  • Europe
  • China

 

 

Terms :

 

Selling :

L/C, Cheque, Bank Transfer and RTGS

 

 

Purchasing :

L/C, Cheque, Bank Transfer and RTGS

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

Customers :

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

No. of Employees :

12000 (approximately)

 

 

Bankers :

Bank Name

Standard Chartered Bank

Branch

Marina Bay Financial Centre Tower 1, Level 23, 8 Marina Boulevard – 018981, Singapore

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

 

Facilities :

 

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Foreign currency term loans from banks

18004.376

0.000

Loans and advances from related parties

107.196

138.075

Short-term borrowings

 

 

Rupee term loans from banks

355.481

367.830

Foreign currency term loans from others

1053.734

3103.766

Total

19520.787

3609.671

 

Auditors :

 

Name :

Apaji Amin and Company LLP

Chartered Accountants

Address :

304, Akansha Building, Opposite Vadilal House, Navrangpura, Ahmedabad – 380009, Gujarat, India

PAN No.:

ABCFA0343D

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiaries 

(As on 29.09.2017) :

·         Accord Farma SA DE CV, Mexico

·         Accord Farmaceutica Ltda., Brazil

·         Accord Healthcare Inc., North Carolina, Usa

·         Accord Healthcare (Pty) Limited, South Africa

·         Accord Healthcare Inc., Canada

·         Accord Healthcare NZ Limited, New Zealand

·         Accord Healthcare Limited, United Kingdom

·         Accord Healthcare Sac, Peru

·         Intas Medi Devices Limited, India [CIN No.U33110GJ2010PLC061475]

·         Andre Laboratories Limited, India [CIN No.U24231GJ1973PLC040442]

·         Astron Research Limited, United Kingdom

·         Accord Healthcare Limited [CIN No. U24231GJ2003PLC041866]

·         Accord Healthcare Pty. Limited, Australia

·         Accord Healthcare SAS, France

·         Accord Healthcare BV, Netherlands

·         Accord Healthcare Italia SRL, Italy

·         Accord Healthcare Sociedad Limitada Spain

·         Accord Healthcare Polska Spolka Z Organiczona Odpowiedzialnoscia, Poland

·         Accord Healthcare AB, Sweden

·         Accord Healthcare BVPA, Belgium

·         Farmabiot SA DE CV, Mexico

·         Accord Healthcare OY, Finland

·         Accord Healthcare GmbH, Austria

·         Accord Healtcare Ireland Limited, Ireland

·         Accord Healthcare SDN. BHD., Malay

·         Accord Healthcare MENA DMCC, UAE

·         Accord Biopharma Inc., USA

·         Accord Healthcare HK Limited, Hong Kong

·         Accord Healthcare s.r.o, Czech Republic

·         Accord Healthcare Private Limited, Singapore

·         Accord Healthcare Pharmaceutical LLC, Slovania

·         Accord Healthcare SRL, Romania

·         Accord Healtcare Unipessoal Lda., Portugal

·         Genim s.r.o., Czech Republic

·         Accord Healthcare GmbH, Germany

·         Accord Healthcare OU, Estonia

·         Accord Healthcare Limited, (Malta)

·         Actavis UK Limited

·         Actavis Ireland Limited

·         Accord Healthcare (Thailand) Limited

 

Associate :

·         Alvi Intas Medical Devices Private Limited

[CIN No.U33110GJ23013PTC073537]

 

Joint Venture  :

·         Alvi-Intas Medical Devices Private Limited

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives

:

·         One Advertising and Communication Services Limited, |India

·         Lambda Therapeutic Research Limited, India

·         Lambda Therapeutic Research Inc., Canada

·         Unipath Specialty Laboratory Limited, India

·         Astron Packaging Limited, India

·         Astron Tours and Travels Private Limited, India

·         Advanced Transfusion Medicine Research Foundation

·         Equatorial Private Limited, India 

·         Intas Enterprise Private Limited, India

·         Intas Welfare Trust, India

·         Cytas Research Limited, India

 

 

CAPITAL STRUCTURE

 

AS ON 29.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

173916752

Equity Shares

INR 10/- each

INR 1739.167 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

114743972

Equity Shares

INR 10/- each

INR 1147.440 Million

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2017

31.03.2016

31.03.2015

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

1147.440

1147.440

1147.440

(b) Reserves & Surplus

61165.689

50792.016

40836.329

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds

62313.129

51939.456

41983.769

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

18119.716

156.111

1057.117

(b) Deferred tax liabilities (Net)

461.227

366.285

1288.703

(c) Other long term liabilities

210.481

203.342

233.732

(d) long-term provisions

916.810

716.086

547.523

Total Non-current Liabilities

19708.234

1441.824

3127.075

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1468.392

4123.419

3850.283

(b) Trade payables

10736.396

10032.564

8934.639

(c) Other current liabilities

516.684

520.558

395.759

(d) Short-term provisions

354.713

312.320

413.198

Total Current Liabilities

13076.185

14988.861

13593.879

 

 

 

 

TOTAL

95097.548

68370.141

58704.723

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

12997.093

10010.407

8986.243

(ii) Intangible Assets

7999.839

9161.502

9910.730

(iii) Capital work-in-progress

3411.377

2645.119

1076.981

(iv) Intangible assets under development

1569.937

1676.828

2959.705

(b) Non-current Investments

5674.741

5512.048

5434.045

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

21625.839

2311.085

3179.557

(e) Other Non-current assets

1645.068

1340.460

4.852

Total Non-Current Assets

54923.894

32657.449

31552.113

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

14520.126

11582.011

7371.431

(c) Trade receivables

21993.879

20639.279

16582.147

(d) Cash and cash equivalents

306.966

237.962

226.765

(e) Short-term loans and advances

11.032

12.968

2972.267

(f) Other current assets

3341.651

3240.472

0.000

Total Current Assets

40173.654

35712.692

27152.610

 

 

 

 

TOTAL

95097.548

68370.141

58704.723

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

65209.494

56754.982

43867.844

 

Other Income

221.209

174.421

534.081

 

TOTAL

65430.703

56929.403

44401.925

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

19578.233

17164.908

14812.585

 

Purchases of Stock-in-Trade

6081.651

5466.118

3989.638

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(1381.757)

(1977.349)

(11.414)

 

Employees benefits expense

8146.097

6570.672

4528.030

 

Exceptional Item

17062.805

13646.775

66.052

 

Other expenses

0.000

4.672

11541.787

 

CSR Expenditure

0.000

0.000

1.751

 

TOTAL

49487.029

40875.796

34928.429

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION 

15943.674

16053.607

9473.496

 

 

 

 

 

Less

FINANCIAL EXPENSES

108.796

180.433

162.871

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

15834.878

15873.174

9310.625

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

2506.473

2404.915

2254.040

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

13328.405

13468.259

7056.585

 

 

 

 

 

Less

TAX

2971.509

2760.677

1430.409

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

10356.896

10707.582

5626.176

 

 

 

 

 

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

28521.402

19897.036

15485.458

 

 

 

 

 

 

Due to Amalgamation and Adjustment relating to Fixed Assets

0.000

0.000

(382.719)

 

 

 

 

 

 

APPROPRIATIONS

 

 

 

 

Transfer to General Reserve

0.000

1100.000

650.000

 

Dividend

0.000

802.285

0.000

 

Tax on Dividend

0.000

163.326

0.000

 

Others

36.173

17.605

0.000

 

Proposed Equity Dividend

0.000

0.000

343.309

 

Corporate Dividend Tax

 

 

69.890

 

Total

36.173

2083.216

1063.199

 

 

 

 

 

 

Balance Carried to the B/S

38842.125

28521.402

19665.716

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

31112.548

28779.607

19857.267

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

90.26

93.32

54.97

 

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

37.914

40.767

26.400

Net cash flows from (used in) operations

12837.944

7832.821

5677.220

Net cash flows from (used in) operating activities

9194.017

4836.710

3629.884

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

[Sundry Debtors / Income * 365]

123.11

132.73

137.97

 

 

 

 

Account Receivables Turnover

[Income / Sunday Debtors]

2.96

2.75

2.65

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

152.72

161.81

173.44

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.10

1.39

1.29

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.61

0.68

0.41

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.33

0.22

0.25

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.31

0.08

0.12

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.21

0.29

0.32

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.42

0.45

0.55

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

146.55

88.97

58.17

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

PAT to Sales

((PAT / Sales) * 100)

%

15.88

18.87

12.83

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

10.89

15.66

9.58

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

16.62

20.62

13.40

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

3.07

2.38

2.00

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

1.96

1.61

1.46

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.66

0.76

0.72

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

17.10

3.77

4.30

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

3.07

2.38

2.00

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

1147.440

1147.440

1147.440

Reserves & Surplus

40836.329

50792.016

61165.689

Money received against share warrants

0.000

0.000

0.000

 Share Application money pending allotment

0.000

0.000

0.000

Net worth

41983.769

51939.456

62313.129

 

 

 

 

long-term borrowings

1057.117

156.111

18119.716

Short term borrowings

3850.283

4123.419

1468.392

Current maturities of long-term debts

26.400

40.767

37.914

Total borrowings

4933.800

4320.297

19626.022

Debt/Equity ratio

0.118

0.083

0.315

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

43867.844

56754.982

65209.494

 

 

29.377

14.897

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

43867.844

56754.982

65209.494

Profit

5626.176

10707.582

10356.896

 

12.83%

18.87%

15.88%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last four years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last four years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

NOTE:

The Registered Office Address has been shifted from 2nd Floor, Chinubhai Centre, Ashram Road, Ahmedabad - 380009, Gujarat, India to the present address.

 

REVIEW OF BUSINESS OPERATIONS AND FUTURE PROSPECTS (As on 31.03.2016)

 

During the year under review, the Company’s standalone Revenue from operations (Net) stood at INR 65209.494 million as compared to INR 56754.982 million for the previous year, representing an increase of 14.90%. Profit before Tax (PBT) stood at INR 13328.405 million for the year as compared to INR 13468.259 million for the previous year, decreased by ~ 1.04%; Net Profit stood at INR 10356.896 million as compared to INR 10707.582 million for the previous year, decreased by ~ 3.28%.

 

UNSECURED LOAN

Particular

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Loans and advances from others

8.144

18.036

Short-term borrowings

 

 

Rupee term loans from banks

14.273

104.774

Foreign currency term loans from banks

44.904

547.049

Total

67.321

669.859

 

 

 

INDEX OF CHARGE:

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

G54698956

100125104

STANDARD CHARTERED BANK

04/09/2017

-

-

1846170150.0

MARINA BAY FINANCIAL CENTRE TOWER 1, LEVEL 23, 8 MARINA BOULEVARD NANA 018981 SG

2

G33228222

100071690

AXIS TRUSTEE SERVICES LIMITED

28/12/2016

-

-

32182903510.29

AXIS HOUSE, BOMBAY DYEING MILLS COMPOUND, PANDHURANG BUDHKAR MARG, WORLI, MUMBAI – 400025, MAHARASHTRA, INDIA

3

G48611784

100072051

AXIS TRUSTEE SERVICES LIMITED

28/12/2016

14/07/2017

-

18458674000.0

AXIS HOUSE, BOMBAY DYEING MILLS COMPOUND, PANDHURANG BUDHKAR MARG, WORLI, MUMBAI – 400025, MAHARASHTRA, INDIA

4

C18867440

90103163

STATE BANK OF INDIA

25/06/1999

21/08/2014

-

5500000000.0

COMMERCIAL BRANCH, PARAM, SIDDHI COMPLEX, ELLISBRIDGE, AHMEDABAD- 380006, GUJARAT, INDIA

5

Y10197374

90107682

DENA BANK

01/05/1998

-

-

45000000.0

ASHRAM ROAD BRANCH, ASHRAM ROAD, AHMEDABAD – 393009, GUJARAT, INDIA

6

G36605764

10373035

BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCIL

30/08/2012

14/02/2014

22/02/2017

181120000.0

A-254, 3RD FLOOR, VEERA TOWER, BHISHAM PITAMAH MARG, DEFENCE COLONY, NEW DELHI – 110024, INDIA

7

G22707319

100019286

CITI BANK N.A.

21/03/2016

07/04/2016

15/11/2016

1150000000.0

PLOT NO. C-61, BANDRA KURLA COMPLEX, G-BLOCK, BANDRA (EAST), MUMBAI – 400051, MAHARASHTRA, INDIA

8

C80416654

10443209

IDBI TRUSTEESHIP SERVICES LIMITED

14/06/2013

-

01/03/2016

900000000.0

ASIAN BLDG., GROUND FLOOR, 17, R. KAMANI MARG, BALLARD ESTATE, MUMBAI – 400001, MAHARASHTRA, INDIA

9

C40621856

10242942

CITIBANK N. A.

10/08/2010

31/03/2011

07/01/2015

500000000.0

301, 3RD FLOOR, REMBRANT BUILDING, OPP. ASSOCIATE PETROL PUMP, C.G. ROAD, AHMEDABAD – 380006, GUJARAT, INDIA

10

C40616278

10256338

CITI BANK N.A.

27/10/2010

24/02/2014

07/01/2015

500000000.0

301, 3RD FLOOR, REMBRANT BUILDING, OPP. ASSOCIATE PETROL PUMP, C.G. ROAD, AHMEDABAD – 380006, GUJARAT, INDIA

 

CONTINGENT LIABILITIES:

 

(INR in million)

PARTICULARS

31.03.2017

31.03.2016

 

 

 

Claims against company not acknowledged as debt

2324.971

2012.402

Guarantees

30890.005

321.079

Other money for which company is contingently liable

1427.415

2640.155

Total

34642.391

4973.636

 

 

FIXED ASSETS

 

·         Land

·         Plant and equipment

·         Furniture and fixtures

·         Vehicles

·         Computer equipments


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 67.52

UK Pound

1

INR 91.48

Euro

1

INR 80.52

 

 

INFORMATION DETAILS

 

Information Gathered by :

POON

 

 

Analysis Done by :

PRI

 

 

Report Prepared by :

RKI

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.